4/5/2023 0 Comments Abilify class actio lawsuitWe only pursue lawsuits on behalf of individuals who were not warned of the risk associated with the dangerous drug, device or product on the market. If these same corporations warn consumers of these risks, there is no case. Unfortunately, too often we see dangerous drugs, devices, and products remain on the market when corporations prioritize profit over people. There is no requirement that a corporation acts morally. They knew the drug could cause these conditions in people and they went ahead and sold it to the public anyway.Ī corporation, by definition, is profit-seeking. In fact, the Abilify drug makers hid evidence from the government when they got FDA approval. In addition to the 2014 studies, the Abilify lawsuits note that both Canada and Europe updated their warnings, but the manufacturer (BMS-Otsuka) failed to warn patients of the dangers in the U.S. In fact, Moore notes, “If you compare the uncontrollable urges to the risk of suicide among patients who take antidepressant drugs, the rate of uncontrollable urges is much higher.” These include uncontrollable gambling, eating, shopping and having sex. A 2014 study by Thomas Moore of the Institute of Safe Medication Practices, noted that urges were not rare. After 14 years of monitoring adverse events, the FDA said the warning was not strong enough.Īccording to Abilify lawsuits, the warning did not reflect the nature of the impulse-control risk. Why Is There An Abilify Lawsuit?Ībilify and its generics previously listed compulsive gambling as a potential side effect for the antipsychotic drug and its generics. We provide you this valuable information so you are prepared to talk to a lawyer. We believe that in order for you to make important decisions about your health and your legal rights, you need to start with information. Yes, there is a tool for that! If you found us today, you are looking for instant answers to whether you should file a lawsuit and we want to help you. We built the Instant Case Evaluator ℠ as a no cost/no obligation place for you to find answers about your legal rights. Have You Seen An Abilify Commercial?ĭid a recent Abilify commercial grab your attention? Did you find our site because you were wondering if you qualify for the Abilify lawsuits? The drug was also marketed as an “add-on treatment for adults with depression when an antidepressant alone is not enough”. It is an antipsychotic medication marketed by a partnership of Bristol-Myers Squibb and Otsuka Pharmaceutical. revenue of $7.8 billion between the years of 2011 to 2016.Ībilify (aripiprazole) was approved in June 2006 to treat the psychotic conditions adult schizophrenia and bipolar disorder. During this same time frame, the FDA issued warnings to the company noting their pharmacology aid was misleading.Ībilify earned U.S. Marketed as “a thermostat to restore balance,” Abilify outsold all other major anti-depressants in 20 combined. For this reason, it should be no surprise that this drug could lead to a number of Abilify lawsuits. market changed actions in the brain in an “unknown” way. There have been over 1,600 filed against the manufacturer of the drug as of July 2018.Ībilify, the 2013 top-selling drug on the U.S. The Abilify lawsuits allege that the manufacturer knew of the risk and did not warn the public of the danger. TruLaw is not currently accepting new Abilify clients.Ībilify lawsuits are currently being filed against Bristol-Meyers-Squibb and Otsuka Pharmaceutical, the manufacturer of the top-selling antipsychotic drug, for its link to gambling and other compulsive behaviors.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |